Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis

Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis

This study aims to determine if continuous infusion (CI) is associated with better clinical and pharmacokinetic/pharmacodynamic (PK/PD) outcomes compared to intermittent bolus (IB) dosing in critically ill patients with severe sepsis. This was a two-centre randomised controlled trial of CI versus I...

Full description

Bibliographic Details
Main Authors: Abdul Aziz, Mohd. Hafiz, Sulaiman, Helmi, Mat Nor, Mohd Basri, Rai, Vineya, Wong, K., Hasan, Mohd Shahnaz, Abd. Rahman, Nurul Azrin, Jamal, Janattul-Ain, Wallis, Steven C., Lipman, Jeffrey, Staatz, Christine E., Roberts, Jason A.
Format: Article
Language:English
English
Published: Springer Verlag 2016
Subjects:
QR Microbiology
RM Therapeutics. Pharmacology
RS Pharmacy and materia medica
Online Access:http://irep.iium.edu.my/49261/6/Abdul-Aziz%20et%20al.%202016.%20Intensive%20Care%20Medicine.pdf
http://irep.iium.edu.my/49261/12/49261_Beta-Lactam%20Infusion_wos.pdf

Similar Items

Similar Items